Body Composition & Wellness
GHK-Cu · BPC-157 · Thymosin Beta-4 · KPV
Research-only peptide supplied as a lyophilized vial for qualified laboratory handling.
Per-vial price
$125.00
Research Context
What researchers are studying
This research-stack preparation combines four constituent peptides — GHK-Cu, BPC-157, Thymosin Beta-4, and KPV — supplied together in a single lyophilized vial. Each component has been characterized separately in published research, and the combined preparation reflects protocols commonly discussed in research forums investigating multi-peptide exposures in preclinical models.
Researchers studying combined peptide protocols in cellular recovery and signaling order this 80 mg lyophilized preparation as a single-vial format. Published work on the constituent peptides covers dermal copper-peptide signaling, soft-tissue repair markers, actin-binding signaling, and anti-inflammatory fragment signaling in rodent and in-vitro systems.
For research laboratory handling only. Not approved for any therapeutic indication.
Handling & Storage
Standard research handling
- Lyophilized blended preparation. Store cool and dry unopened; refrigerate at 2–8 °C.
- Reconstitute with bacteriostatic water (3 mL) before laboratory handling.
- Refrigerate after reconstitution and use within the standard research window.
Green Chemistry
Our sourcing commitments
Verified Synthesis Partners
Sourced from established peptide manufacturers operating under GMP-aligned quality frameworks.
Batch-Level Third-Party Validation
Every batch undergoes independent purity and identity testing before dispatch.
Controlled Cold-Chain Handling
Lyophilised preparations are handled and shipped under controlled temperature conditions.
Responsible Packaging
Packaging materials selected for minimal environmental footprint; vials and outer materials are recyclable.
This product is supplied for research use only (RUO). It is not approved for human use or any therapeutic indication.
Certificate of Analysis
Per-lot testing reports
Each lot is independently tested by a third-party laboratory before release. Per-lot Certificates of Analysis are published for every batch of this preparation and made available as downloadable PDFs.
- Lot Blue Cap·Tested 2026-07-20·Freedom Diagnostics
Lot QC for the KLOW 80 mg research preparation (blend of GHK-Cu, KPV, BPC-157, and Thymosin Beta-4). Identity of each constituent peptide confirmed by LC-MS on the per-lot sheet — reported component amounts: GHK-Cu 65.77 mg, KPV 12.32 mg, BPC-157 13.00 mg, Thymosin Beta-4 13.09 mg; appearance: blue lyophilized powder. The 99.64% purity result is a single-lot analytical measurement on a formulated mixture; the PDP does not make a product-level purity marketing claim for this blend.
This preparation is supplied for research use only (RUO). It is not approved for human use or any therapeutic indication.
Quality Standards
Sourced to research-grade standards
Sourced to research-grade standards. Each batch is handled under controlled conditions and verified by third-party testing before shipment.
For research use only. Age 21+ acting on behalf of a qualified laboratory, institution, or business.